- Home
- VTVT
as 03-26-2025 1:36pm EST
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | HIGH POINT |
| Market Cap: | 38.8M | IPO Year: | 2015 |
| Target Price: | $35.00 | AVG Volume (30 days): | 48.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.12 - $29.19 | Next Earning Date: | 03-20-2025 |
| Revenue: | $1,017,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest vTv Therapeutics Inc. News
VTVT Breaking Stock News: Dive into VTVT Ticker-Specific Updates for Smart Investing
Zacks
6 days ago
The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics
Associated Press Finance
6 days ago
VTv Therapeutics: Q4 Earnings Snapshot
GlobeNewswire
7 days ago
vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Clinical Trials Arena
9 days ago
FDA removes hold on vTv’s cadisegliatin clinical programme for diabetes
GuruFocus.com
10 days ago
vTv Therapeutics Soars 43% as FDA Lifts Clinical Hold on Diabetes Drug Trial
GuruFocus.com
10 days ago
FDA Lifts Clinical Hold-vTv Stock Jumps Nearly 28% on Diabetes Drug Progress
MT Newswires
10 days ago
Vtv Therapeutics Says FDA Lifts Clinical Hold on Cadisegliatin Program for Diabetes; Shares Up Pre-Bell
GlobeNewswire
10 days ago
vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes
Compare VTVT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VTVT vTv Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.